The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering.

Mohajeri, Abbas; Sanaei, Sarvin; Kiafar, Farhad; Fattahi, Amir; Khalili, Majid; Zarghami, Nosratollah.

Afiliação

Mohajeri A; Department of Biotechnology, Zahravi Pharmaceutical Company, Tabriz, Iran.
Sanaei S; Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Kiafar F; Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Fattahi A; Department of Biotechnology, Zahravi Pharmaceutical Company, Tabriz, Iran.
Khalili M; Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Zarghami N; Department of Basic Science, Maragheh University of Medical Sciences, Maragheh, Iran.

Adv Pharm Bull ; 7(1): 21-34, 2017 Apr.

Article em En | MEDLINE | ID: mdl-28507934